CommercialPrior AuthMedium impact
Pharmacy Medical Policy Updates
Blue Cross Blue Shield of Kansas·KS · Endocrinology, Oncology, Urology +2 more·Pharmacy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Blue Cross Blue Shield of Kansas updated 15 pharmacy medical policies effective October 1, 2025, including medications for diabetes (GLP-1 Agonists), oncology, weight management, and other specialty drugs. These updates likely affect prior authorization requirements, quantity limits, and coverage criteria for affected medications.
Action Required
By October 1, 2025: Billing team must review updated pharmacy medical policies for Ctexli, Elmiron, GLP-1 Agonists, IL-1 Inhibitor, Phosphate Binder, PPI, Resmetirom, SA Oncology, Sensipar, Topiramate ER, Urinary Incontinence, Vanrafia, Weight Management, Xdemvy, Xphosah, and Yorvipath on BCBSKS website. Update prior authorization workflows and verify coverage requirements for these medications before prescribing or billing. Contact BCBSKS provider relations representative with questions.